Harvard Bioscience Income Statement (2010-2026) | HBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	29.20M	29.66M	33.05M	28.78M	29.21M	26.92M	28.43M	29.98M	28.76M	25.36M	28.15M	24.51M	23.10M	21.97M	24.56M	21.77M	20.45M	20.59M	23.73M	20.75M
Cost of Revenue (Quarter)	12.84M	13.36M	13.49M	12.60M	12.57M	14.75M	12.59M			10.64M	11.83M	0.97M	0.25M	9.21M	10.54M	9.59M	0.20M	0.05M	-26.35M	0.23M
Gross Profit (Quarter)	16.35M	16.31M	19.56M	16.18M	16.64M	12.17M	15.83M	18.35M	16.67M	14.73M	16.32M	14.77M	13.22M	12.77M	14.01M	12.18M	11.53M	12.02M	14.17M	12.24M
Operating items
Amortization - Intangibles (Quarter)	1.47M	1.46M	1.44M	1.47M	1.50M	1.57M	1.60M	1.39M	1.39M	1.36M	1.39M	1.33M	1.33M	1.33M	1.26M	1.16M	1.16M	0.85M	0.85M	0.82M
Research & Development (Quarter)	2.70M	2.66M	16.79M	6.69M	3.50M	2.76M	5.95M	5.98M	2.96M	2.76M	15.45M	5.90M	5.39M	5.52M	5.39M	4.97M	4.54M	2.13M	12.57M	5.33M
Selling, General & Administrative (Quarter)	6.40M	5.46M	6.12M	6.33M	5.98M	6.32M	5.86M	6.33M	5.35M	5.81M	5.26M	5.96M	5.69M	5.04M	4.80M	5.18M	4.26M	4.18M	4.12M	4.70M
Restructuring Costs (Quarter)			0.30M	5.19M	-4.90M	-0.54M							0.40M	0.18M		0.09M	0.03M	0.05M		0.20M
Other Operating Expenses (Quarter)	7.20M	7.64M	-5.35M	4.69M	8.06M	7.39M	4.48M	4.29M	7.57M	7.09M	-4.67M	5.18M	3.81M	3.90M	3.80M	51.60M	3.52M	5.47M	-4.23M	3.18M
Operating Expenses (Quarter)	16.30M	15.76M	17.86M	22.89M	12.64M	15.93M	16.29M	16.60M	15.88M	15.66M	16.04M	17.05M	15.29M	14.64M	14.00M	61.85M	12.35M	11.82M	12.46M	13.42M
Operating Income (Quarter)	0.06M	0.55M	1.70M	-6.71M	4.00M	-3.76M	-0.46M	1.75M	0.80M	-0.93M	0.28M	-2.28M	-2.07M	-1.87M	0.01M	-49.67M	-0.82M	0.20M	1.71M	-1.17M
EBIT (Quarter)	0.06M	0.55M	1.70M	-6.71M	4.00M	-3.76M	-0.46M	1.75M	0.80M	-0.93M	0.28M	-2.28M	-2.07M	-1.87M	0.01M	-49.67M	-0.82M	0.20M	1.71M	-1.17M
Non-operating items
Non Operating Investment Income (Quarter)									-1.58M	1.21M	-0.26M	-1.31M	-0.28M
Other Non Operating Income (Quarter)	-0.31M	-0.13M	5.58M	0.08M	-0.06M	-0.18M	0.47M	0.43M	-0.37M	0.04M	-0.33M	-0.14M	-0.18M	-0.52M	0.52M	-0.19M	-0.64M	-0.36M	1.84M	-0.41M
Non Operating Income (Quarter)	-0.69M	-0.37M	-0.57M	-0.31M	-0.58M	-0.93M	-0.60M	-0.54M	-2.89M	0.37M	-1.39M	-0.75M	-0.75M	-2.62M	0.58M	-1.13M	-1.44M	-1.33M	-6.25M	-2.13M
Net income details
EBT (Quarter)	-0.63M	0.04M	1.13M	-7.02M	3.42M	-4.69M	-0.89M	1.21M	-2.10M	-0.56M	-1.10M	-4.48M	-3.28M	-4.49M	0.59M	-50.79M	-2.25M	-1.13M	-3.20M	-3.31M
Tax Provisions (Quarter)	-0.20M	0.21M	-0.01M	-0.10M	1.00M	-1.28M	0.77M	0.60M	-1.10M	0.68M	-0.64M	0.21M	-0.35M	0.30M	0.23M	-0.50M	0.03M	0.10M	-0.39M	0.12M
Profit After Tax (Quarter)	-0.41M	-0.17M	0.96M	-6.88M	2.44M	-3.40M	-1.67M	0.62M	-0.98M	-1.24M	-1.82M	-4.69M	-2.93M	-4.80M	0.02M	-50.34M	-2.28M	-1.23M	-2.85M	-3.42M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-0.43M	-0.17M	1.14M	-6.92M	2.42M	-3.40M	-1.67M	0.61M	-1.00M	-1.24M	-0.47M	-4.69M	-2.93M	-4.79M	0.36M	-50.29M	-2.28M	-1.23M	-2.82M	-3.42M
Income from Discontinued Operations (Quarter)
Consolidated Net Income (Quarter)	-0.43M	-0.17M	1.14M	-6.92M	2.42M	-3.40M	-1.67M	0.61M	-1.00M	-1.24M	-0.47M	-4.69M	-2.93M	-4.79M	0.36M	-50.29M	-2.28M	-1.23M	-2.82M	-3.42M
Income towards Parent Company (Quarter)	-0.43M	-0.17M	1.14M	-6.92M	2.42M	-3.40M	-1.67M	0.61M	-1.00M	-1.24M	-0.47M	-4.69M	-2.93M	-4.79M	0.36M	-50.29M	-2.28M	-1.23M	-2.82M	-3.42M
Net Income towards Common Stockholders (Quarter)	-0.43M	-0.17M	1.14M	-6.92M	2.44M	-3.40M	-1.67M	0.61M	-0.98M	-1.24M	-0.47M	-4.69M	-2.93M	-4.79M	0.36M	-50.29M	-2.28M	-1.23M	-2.82M	-3.42M
Additional items
EPS (Basic) (Quarter)	-0.11	-0.04	0.28	-1.68	0.59	-0.82	-0.40	0.14	-0.23	-0.29	-0.11	-1.08	-0.67	-1.10	0.08	-11.41	-0.52	-0.28	-0.63	-0.77
EPS (Diluted) (Quarter)	-107.60	-0.04	0.28	-1.68	0.57	-0.82	-0.40	0.14	-0.23	-0.29	-0.11	-1.08	-0.67	-1.10	0.08	-11.41	-0.52	-0.28	-0.63	-0.77
Shares Outstanding (Quarter)	4.02M	4.08M	4.03M	4.12M	4.13M	4.16M	4.14M	4.21M	4.24M	4.27M	4.24M	4.34M	4.35M	4.36M	4.35M	4.41M	4.43M	4.46M	4.44M	4.47M
Shares Outstanding (Diluted) (Quarter)	0.00M	4.08M	4.03M	4.12M	4.26M	4.16M	4.14M	4.28M	4.24M	4.27M	4.24M	4.34M	4.35M	4.36M	4.35M	4.41M	4.43M	4.46M	4.44M	4.47M
Shares Outstanding (Entity) (Quarter)	4.05M	4.08M	4.11M	4.12M	4.15M	4.17M	4.21M	4.22M	4.27M	4.27M	4.34M	4.34M	4.36M	4.36M	4.41M	4.42M	4.45M	4.46M	4.47M	4.51M
EBITDA (Quarter)	0.06M	0.55M	1.70M	-6.71M	4.00M	-3.76M	-0.46M	1.75M	0.80M	-0.93M	0.28M	-2.28M	-2.07M	-1.87M	0.01M	-49.67M	-0.82M	0.20M	1.71M	-1.17M
Interest Expenses (Quarter)	4.28M	12.30M	-0.79M	2.37M	2.36M	10.43M	0.59M	1.34M	2.28M	1.34M	-1.91M	1.09M	1.77M	1.48M	-1.57M	0.94M	1.77M	0.95M	1.17M	1.43M
Tax Rate (Quarter)	31.65%	477.78%	-0.62%	1.42%	29.23%	27.40%	-86.77%	49.71%	52.43%	-120.46%	57.75%	-4.68%	10.76%	-6.68%	38.98%	0.98%	-1.33%	-8.55%	12.05%	-3.54%

Research Tools

Developers

Harvard Bioscience Income Statement (2010-2026) | HBIO

Research Tools

Developers

Harvard Bioscience Income Statement (2010-2026) | HBIO

Create an account

Sign In

Reset Password